Cerity Partners LLC Acquires 6,167 Shares of ResMed Inc. (NYSE:RMD)
Cerity Partners LLC increased its stake in ResMed Inc. (NYSE:RMD – Free Report) by 82.0% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The ...
Is ResMed Inc.'s (NYSE:RMD) Recent Performance Tethered To Its Attractive Financial Prospects?
Most readers would already know that ResMed's (NYSE:RMD) stock increased by 2.6% over the past month. Since the ...
Insider Activity: Resmed Inc Director’s Share Sales
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update.Don't Miss our Black Friday ...
Taiwan News2d
Digital Therapeutics Market Size, Revenue, Growth, Segments by Region, Company, Type and Sales Channels Forecast 2032
The global digital therapeutics market revenue was US$ 3,537.25 million in 2020. The global digital therapeutics market revenue is forecast to reach US$ 23,569.34 million by 2030, growing at a ...
Future Market Insights2d
Global Acoustic Respiration Sensors Market Set for Remarkable Growth, Reaching USD 468.9 Million by 2033
Recent Developments by Key Players: Major players in the respiration rate monitors market are GE Healthcare, Siemens ...
ResMed Inc. stock falls Wednesday, still outperforms market
Shares of ResMed Inc. RMD slipped 0.26% to $249.33 Wednesday, on what proved to be an all-around rough trading session for ...
AFIC bosses on its record discount, passive investing and pricey stocks
A triple headwind has seen Australia's biggest LIC swing to a 10% discount and scuppered its relative performance. Management ...
ResMed Inc’s Peter Farrell Alters Stock Holdings
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update.Don't Miss our Black Friday ...
Livewire Markets3d
The US dollar is soaring – So which ASX stocks stand to benefit?
For instance, Aristocrat Leisure says a single US cent change in the AUD/USD exchange rate could translate to an estimated ...
Downgrading ResMed Inc. Because It's Doing Well
ResMed Inc. is downgraded from buy to watchful hold due to valuation concerns, despite strong financial performance and ...
ResMed: Solid Execution, Pricey Valuation
Analyzing ResMed Inc.'s Q1 2025 results, stock performance, and sentiment to determine if further upside or profit taking is ...
kalkinemedia5d
ResMed's Strong Recent Performance and Long-Term Success
Highlights,-ResMed delivered a 71% total return over five years.,-EPS grew 21% annually, outpacing stock price gains.,-A 60% ...